Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 14;5(5):e12546.
doi: 10.1002/rth2.12546. eCollection 2021 Jul.

Tranexamic acid evidence and controversies: An illustrated review

Nicole Relke  1 , Nicholas L J Chornenki  1 , Michelle Sholzberg  2   3   4
Affiliations
Review

Tranexamic acid evidence and controversies: An illustrated review

Nicole Relke et al. Res Pract Thromb Haemost. .

Abstract

Tranexamic acid (TXA) is an antifibrinolytic agent commonly used for the treatment or prevention of bleeding. Indications for TXA are diverse, including heavy menstrual bleeding, trauma, postpartum hemorrhage, traumatic brain injury, and surgical site bleeding. Despite decades of use and a robust body of evidence, hesitancy using TXA persists in many clinical settings. This illustrated review describes the history, pharmacology, and practical considerations of TXA use. We also describe the major landmark randomized controlled trials of TXA and their implications. Finally, we review the evidence around common controversies surrounding TXA such as the risk of thrombosis, prescription along with combined hormonal contraceptives, and use in patients with gross hematuria.

Keywords: antifibrinolytic agents; blood coagulation; contraceptive agents; thrombosis; tranexamic acid.

PubMed Disclaimer

References

    1. Watts G. Utako Okamoto (Obituary). Lancet. 2016;387:2286. - PubMed
    1. Okamoto S, Okamoto U. Amino‐methyl‐cyclohexane‐carboxylic acid: AMCHA. A new potent inhibitor of fibrinolysis. Keio J Med. 1962;11:105‐115.
    1. Olldashi F, Kerçi M, Zhurda T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH‐2): a randomised, placebo‐controlled trial. Lancet. 2010;376:23‐32. - PubMed
    1. WHO Expert Committee . The selection and use of essential medicines (including the 17th WHO model list of essential medicines). WHO Tech Rep Ser [Internet]. 2011;2011:1‐249.
    1. Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post‐partum haemorrhage (WOMAN): an international, randomised, double‐blind, placebo‐controlled trial. Lancet. 2017;389:2105‐2116. - PMC - PubMed